Pharmacokinetics and Pharmacodynamics of High-Dose PiperacillinTazobactam in Obese Patients

JJ Veillette, SA Winans, VK Maskiewicz… - … and Pharmacokinetics, 2021 - Springer
… 6 h in hemodialysis patients to a 27 g/24-h continuous infusion in a patient with a short PT
half-… Predicted free steady-state piperacillin troughs on 4.5 g every 6 h are displayed in Fig. 1, …

Similar piperacillin/tazobactam target attainment in obese versus nonobese patients despite differences in interstitial tissue fluid pharmacokinetics

D Busse, P Simon, D Petroff, C Dorn, L Schmitt… - Pharmaceutics, 2021 - mdpi.com
… Simulated steady-state concentrations were 1.43-times, 95%CI = (1.27; 1.61), higher in …
We could further show that prolonged and continuous infusions might be necessary for MIC …

Population pharmacokinetics of continuous infusion of piperacillin/tazobactam in very elderly hospitalized patients and considerations for target attainment against …

PG Cojutti, E Morandin, M Baraldo, F Pea - International journal of …, 2021 - Elsevier
… population pharmacokinetic analysis of CI piperacillin/tazobactamsteady-state concentration
(Css) of increasing piperacillin/tazobactam regimens (from 2.25 to 18 g daily by continuous

Piperacillin-tazobactam in intensive care units: a review of population pharmacokinetic analyses

I El-Haffaf, JA Caissy, A Marsot - Clinical pharmacokinetics, 2021 - Springer
… Simulations showed that continuous or extended infusionadministration to achieve appropriate
pharmacodynamic … important pharmacokinetic elements for piperacillin-tazobactam in an …

Pharmacokinetics, pharmacodynamics, and dosing considerations of novel β-lactams and β-lactam/β-lactamase inhibitors in critically ill adult patients: focus on …

D Bakdach, R Elajez, AR Bakdach, A Awaisu… - Journal of Clinical …, 2022 - mdpi.com
… reported with meropenem and piperacillin-tazobactam, with faster … Pharmacokinetics,
safety and tolerability of high-dose ceftobiprole medocaril administered as prolonged infusion

Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion PiperacillinTazobactam or Meropenem and Microbiological Outcome among Urologic …

PM Berrino, M Gatti, M Rinaldi, E Brunocilla, P Viale… - Antibiotics, 2023 - mdpi.com
… : Patients admitted to the urology ward who were treated with CI piperacillintazobactam or
… Average steady-state (C ss ) piperacillintazobactam and meropenem concentrations were …

Could an Optimized Joint Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Piperacillin-Tazobactam Be a Valuable Innovative Approach …

M Gatti, M Rinaldi, T Tonetti, A Siniscalchi, P Viale… - Antibiotics, 2023 - mdpi.com
… exposure were performed, with a median (IQR) of 2 (1–2.5) assessments per patient. Median
(IQR) piperacillin and tazobactam free steady-state concentrations (fC ss ) were 54.6 mg/L (…

An integral pharmacokinetic analysis of piperacillin and tazobactam in plasma and urine in critically ill patients

E Wallenburg, R Ter Heine, JA Schouten… - … pharmacokinetics, 2022 - Springer
… were allometrically scaled to a standardized fat-free mass of 58.2 kg [… concentrations were
predicted at steady-state. … based on patients receiving piperacillin as a continuous infusion. To …

Extended infusion versus intermittent infusion of Piperacillin/tazobactam: altering current methods to optimize future outcome

A Alenazi, N Alhamed, M Aldhafeeri… - Pharmacy …, 2023 - pharmacypractice.org
… of an extended infusion in critically ill obese patients. However, … piperacillin/tazobactam
using Monte Carlo simulations and steady-state pharmacokinetic data from hospitalized patients

International consensus recommendations for the use of prolongedinfusion beta‐lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British …

LT Hong, KJ Downes, A FakhriRavari… - … Pharmacology and …, 2023 - Wiley Online Library
… ill adult patients, pediatric patients, and obese patients. … Piperacillintazobactam has been
studied as a simulated 12 … % fT >MIC with steady-state concentrations exceeding a minimum …